Skip to content

Puramed Bioscience Inc.

company.status.inactive

CIK 1409565fmd_0T22DSRFVKJVREQAZWZ0ZJXJTYManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jul 01, 2010 to Sep 30, 2014, 17 periods

Latest annual · FY2014

Millions
Total revenues
0
Gross profit
(0)
Operating income
(3)
Net income
(5)
Free cash flow
(1)

Latest quarter · Q1 FY2015

Millions
Total revenues
0
Gross profit
(0)
Operating income
(0)
Net income
(1)
Free cash flow
(0)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2011 to FY2014
n/m

Puramed Bioscience Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2014FY2013ChangeSource
Revenue$0$42,807-100%10-K 2014-10-14 · proof
Gross profit-$443,861-$52,52710-K 2014-10-14 · proof
Operating income-$2.7 million-$2 million10-K 2014-10-14 · proof
Net income-$5.2 million-$2.6 million10-K 2014-10-14 · proof
Cash from operating activities-$797,571-$1.3 million10-K 2014-10-14 · proof
Free cash flow-$801,458-$1.3 million10-K 2014-10-14 · proof
Total assets$186,338$476,346-60.9%10-K 2014-10-14 · proof
Total liabilities$5.3 million$3.2 million+64%10-K 2014-10-14 · proof
Cash and cash equivalents$48,576$41,180+18%10-K 2014-10-14 · proof
What was Puramed Bioscience Inc.'s revenue in fiscal 2014?
Puramed Bioscience Inc. reported revenue of $0 for fiscal 2014 (the year ended Jun 30, 2014), against $42,807 the year before (-100%). Source: the 10-K filed with the SEC on Oct 14, 2014. SEC
What was Puramed Bioscience Inc.'s gross profit in fiscal 2014?
Puramed Bioscience Inc. reported gross profit of -$443,861 for fiscal 2014 (the year ended Jun 30, 2014), against -$52,527 the year before. Source: the 10-K filed with the SEC on Oct 14, 2014. SEC
What was Puramed Bioscience Inc.'s operating income in fiscal 2014?
Puramed Bioscience Inc. reported operating income of -$2.7 million for fiscal 2014 (the year ended Jun 30, 2014), against -$2 million the year before. Source: the 10-K filed with the SEC on Oct 14, 2014. SEC
What was Puramed Bioscience Inc.'s net income in fiscal 2014?
Puramed Bioscience Inc. reported net income of -$5.2 million for fiscal 2014 (the year ended Jun 30, 2014), against -$2.6 million the year before. Source: the 10-K filed with the SEC on Oct 14, 2014. SEC
What was Puramed Bioscience Inc.'s cash from operating activities in fiscal 2014?
Puramed Bioscience Inc. reported cash from operating activities of -$797,571 for fiscal 2014 (the year ended Jun 30, 2014), against -$1.3 million the year before. Source: the 10-K filed with the SEC on Oct 14, 2014. SEC
What was Puramed Bioscience Inc.'s free cash flow in fiscal 2014?
Puramed Bioscience Inc. reported free cash flow of -$801,458 for fiscal 2014 (the year ended Jun 30, 2014), against -$1.3 million the year before. Source: the 10-K filed with the SEC on Oct 14, 2014. SEC
What are Puramed Bioscience Inc.'s total assets?
As of Jun 30, 2014, Puramed Bioscience Inc. reported total assets of $186,338, against $476,346 a year earlier (-60.9%). Source: the 10-K filed with the SEC on Oct 14, 2014. SEC
What are Puramed Bioscience Inc.'s total liabilities?
As of Jun 30, 2014, Puramed Bioscience Inc. reported total liabilities of $5.3 million, against $3.2 million a year earlier (+64%). Source: the 10-K filed with the SEC on Oct 14, 2014. SEC
What are Puramed Bioscience Inc.'s cash and cash equivalents?
As of Jun 30, 2014, Puramed Bioscience Inc. reported cash and cash equivalents of $48,576, against $41,180 a year earlier (+18%). Source: the 10-K filed with the SEC on Oct 14, 2014. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1409565&period_type=annual&limit=5"

Information only, not investment advice.